Swiss study tracks Real-World IBD treatment choices
NCT ID NCT04989907
First seen Jan 09, 2026 · Last updated Jun 11, 2026 · Updated 23 times
Summary
This study watched 92 adults with inflammatory bowel disease (Crohn's or ulcerative colitis) who were taking vedolizumab as either an IV infusion or a shot under the skin. Researchers did not give any treatment but simply recorded which route patients chose, why they switched or stopped, and how long they stayed on the medicine. The goal was to understand real-world treatment patterns, not to test a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHNS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bauchzentrum INSELSPITAL, Universitatsspital Bern
Bern, 3010, Switzerland
-
Clarunis AG
Basel, 4002, Switzerland
-
Gastroenterologische Praxis Balsiger, Seibold & Partner Crohn-Colitis-Zentrum
Bern, 3012, Switzerland
-
Kantonsspital St. Gallen
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
-
Universitatsspital Zurich
Zurich, 8091, Switzerland
-
Zentrum fur Gastroenterologie und Hepatologie AG
Zurich, 8048, Switzerland
Conditions
Explore the condition pages connected to this study.